Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D2.33 - Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough
D2.34 - Generalized allergic contact dermatitis: a case report
D2.35 - Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation
D2.36 - Clinical Outcomes Of Dental Procedures In Patients With Hereditary Angioedema
D2.37 - Prevalence of food cross-sensitization due to PR-10 proteins among patients of different age groups
D2.38 - Clinical Evaluation of Alternaria alternata Extract Used for Skin Prick Test in Diagnosis of Alternaria alternata Allergy
D2.39 - Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test
D2.42 - Clinical relevance of secondary sensitizations to indoor allergens in patients with persistent allergic rhinitis in a region with high prevalence of dust mite allergy
D2.43 - Implementation of the New Italian Health Care Price List: Impact on Allergy Diagnostics
D2.44 - Kiwi Allergy in Singaporean Children
D2.45 - Specific IgE for inhalant allergens: A cutoff of 0.35 kUA/L is too low
D2.46 - Prevalence and prognosis of food allergies after liver transplantation in children
D2.167 - Effect of Metformin on allergen specific immunotherapy
D2.169 - Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children
D2.174 - Patient survey to determine the minimal clinically important difference for a combined symptom and medication score in grass AIT
D2.179 - Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study
D2.168 - Systemic reactions to subcutaneous immunotherapy in children
D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season
D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment
D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download